Ppp4r1l Activators refers to a group of compounds that specifically increase the activity of Ppp4r1l, the regulatory subunit believed to be associated with the protein phosphatase PP4 complex. In cellular biochemistry, the PP4 complex plays a crucial role in various signal transduction pathways, primarily through its activity in dephosphorylating target proteins, thereby modifying their function and interactions. The activators targeting Ppp4r1l would be designed to enhance its regulatory influence on the PP4 complex, potentially by direct interaction that triggers a conformational change in the protein, which in turn increases the phosphatase's catalytic efficiency. Alternatively, such activators could exert their effects by stabilizing the PP4 holoenzyme complex, thus promoting a more robust dephosphorylation process, or by facilitating a more effective substrate recognition and binding, thereby augmenting the overall substrate turnover rate.
In the laboratory, the study of Ppp4r1l activators would involve meticulous biochemical characterization to ascertain their mode of action. Enzyme kinetics assays would be instrumental in determining how these activators affect the phosphatase activity of the PP4 complex, measuring changes in dephosphorylation rates of specific substrates. Such assays could provide valuable data on changes in the kinetics parameters such as V_max (maximum rate) and K_m (substrate concentration at half-maximum velocity), offering clues about the activators' efficacy. Complementary to these functional assays, structural biology techniques like X-ray crystallography, NMR, or cryo-electron microscopy would be employed to visualize the binding of activators to Ppp4r1l and any resultant structural rearrangements. This structural insight would be pivotal in understanding the exact mechanism by which Ppp4r1l activators exert their effect and could guide the refinement of these molecules to enhance their specificity and potency. These studies would provide a thorough understanding of Ppp4r1l activators' biological role in modulating the PP4 complex without delving into any potential application in health or disease states.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an HDAC inhibitor that can alter chromatin structure and potentially increase the transcription of various genes, including those related to PP4. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
As a DNA methyltransferase inhibitor, it can affect DNA methylation patterns and possibly upregulate genes that are otherwise silenced. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects glycogen synthase kinase 3 (GSK-3) activity and may influence the Wnt signaling pathway, potentially altering gene expression profiles. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Sodium valproate is another HDAC inhibitor that might broadly affect gene expression, including that of regulatory proteins like Ppp4r1l. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression through its nuclear receptors and could potentially affect the transcription of regulatory subunits of phosphatases. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to affect various signaling pathways and could potentially modulate gene expression through epigenetic mechanisms. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin may change the activity of transcription factors and alter gene expression profiles, including those of phosphatases. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), it might influence transcription factors regulated by JNK and alter gene expression. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
By inhibiting p38 MAP kinase, SB203580 could affect downstream signaling pathways and potentially gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that could prevent the activation of the MAPK/ERK pathway, potentially altering expression of genes regulated by this pathway. | ||||||